Saturday, November 05, 2011 7:33:49 PM
Food and Drug Administration inspectors said Roche Holding AG's (RHHBY, ROG.VX) Genentech unit didn't follow proper procedures designed to prevent contamination of drugs such as Avastin.
The FDA released an inspection report Friday dated Sept. 27 involving a plant in Alameda, Calif., that makes the cancer drug Avastin. Parts of the report were blacked out. However, much of the report discussed problems related to caps used to cover the Avastin vials and the capping process.
The report said the company found particles in some Avastin vials, which were sent for analysis. The company also found a problem with disintegrating gaskets. But the FDA said the company didn't compare the particles in the Avastin vials with the disintegrating gasket material "in order to rule out potential...contamination of this lot." The FDA said the vials in question were quarantined and it doesn't appear any of the product was released. It wasn't clear from the FDA's inspection report if the two problems were related.
Genentech couldn't immediately comment on the inspection report. Such reports list observations found during FDA inspections but they don't represent a determination about whether a manufacturer has violated FDA manufacturing rules.
In the report, the FDA said the Avastin caps are made by a contract manufacturer. The caps are shipped inside folded, non-sealed plastic bags inside a cardboard box. FDA said there are no data or controls to assure that the manner in which the caps are shipped doesn't affect "cap integrity" or prevent contamination.
There also appeared to be a separate problem with an oil leak in a machine that caps the Avastin vials. The company stopped production to fix the problem, but the FDA said it wasn't documented that the problem was fixed before production was resumed. The agency also said the company's report about the problem didn't state what happened to the Avastin vials that were on the manufacturing line during the shutdown and repair period.
Avastin is one of Roche's top-selling products, and is approved to treat certain types of lung, brain, kidney, colon and breast cancers, although sales have slipped in the U.S. Roche is fighting to keep the FDA from revoking the approval for breast cancer after clinical studies called into question the product's effectiveness for that type of cancer.
-By Jennifer Corbett Dooren, Dow Jones Newswires, 202-862-9294; jennifer.corbett@dowjones.com
http://ih.advfn.com/p.php?pid=nmona&article=49818109
Recent RHHBY News
- Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives • AllPennyStocks.com • 09/10/2024 10:53:00 PM
- Roche's Cancer Injection Tecentriq SC Gets European Commission Approval • Dow Jones News • 01/16/2024 06:49:00 AM
- Beyond Diabetes, a Blockbuster Horizon Beckons • InvestorsHub NewsWire • 01/10/2024 01:45:00 PM
- LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche • Dow Jones News • 12/29/2023 10:07:00 PM
- Roche's Xolair Granted FDA Priority Review • Dow Jones News • 12/19/2023 03:27:00 PM
- Poseida Therapeutics Shares Climb on Positive Data for Blood Cancer Treatment • Dow Jones News • 12/11/2023 03:31:00 PM
- Roche Obtains Positive Data on Early-Stage Breast Cancer Treatment • Dow Jones News • 12/08/2023 05:56:00 PM
- Roche's Inavolisib Breast Cancer Drug Gets Positive Results • Dow Jones News • 12/08/2023 05:38:00 PM
- Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials • Dow Jones News • 12/06/2023 10:14:00 AM
- Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study • Dow Jones News • 12/05/2023 06:54:00 AM
- Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion • Dow Jones News • 12/04/2023 03:12:00 PM
- Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update • Dow Jones News • 12/04/2023 11:34:00 AM
- Alaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and More • IH Market News • 12/04/2023 10:55:07 AM
- Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Billion • Dow Jones News • 12/04/2023 06:47:00 AM
- Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI • Dow Jones News • 11/21/2023 04:06:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 10:14:35 PM
- Roche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main Goal • Dow Jones News • 10/31/2023 06:26:00 AM
- Roche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion Treatment • Dow Jones News • 10/27/2023 05:40:00 AM
- Trending: Roche to Buy Telavant From Roivant and Pfizer • Dow Jones News • 10/23/2023 07:41:00 PM
- Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update • Dow Jones News • 10/23/2023 08:16:00 AM
- Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal • Dow Jones News • 10/23/2023 05:50:00 AM
- Roche Shares Fall on Lower Sales Due to Currency Hit • Dow Jones News • 10/19/2023 09:55:00 AM
- Roche Backs Guidance After Sales Fall • Dow Jones News • 10/19/2023 05:48:00 AM
- Roche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage Trial • Dow Jones News • 10/18/2023 06:14:00 AM
- Roche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal Sepsis • Dow Jones News • 10/18/2023 05:54:00 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM